Nimbus-T Global | Secure Identity Management
  • Home
  • Nimbus-Key
    • Secure Identity
    • Smart directory
    • Secure Messaging
    • Telehealth
    • Blockchain
  • Cyber Guide
  • About
    • Contact Us
  • Register
  • Blog
Select Page
Tool monitors flu mutations in real time

Tool monitors flu mutations in real time

by Todd Bates-Rutgers | Feb 19, 2020 | Precision Medicine, Digital Health, Healthcare Innovation, news

A new tool can monitor influenza A virus mutations in real time, researchers report.

Regenerative medicine companies raised $4.8B in first half of 2019

Regenerative medicine companies raised $4.8B in first half of 2019

by Alaric DeArment | Aug 9, 2019 | Precision Medicine, Genomics, Healthcare Innovation

Two new approvals, more than 1,000 clinical trials underway and nearly $5 billion raised.

Blog Stats

  • 30,339 hits

Recent Posts

  • Passwordless tech startup Beyond Identity raises $75 million
  • Vulnerability Exposes F5 BIG-IP Systems to Remote DoS Attacks
  • Google closes $2.1B acquisition of Fitbit as Justice Department probe continues
  • CISA Warns Organizations About Attacks on Cloud Services
  • Vulnerabilities Can Allow Hackers to Create Backdoors in Comtrol Industrial Gateways

Categories

  • AI
  • Banking
  • Big Data
  • Biopharma
  • Blockchain
  • Clinical Trials
  • Concierge Medicine
  • Covid-19 / Coronavirus
  • Cryptocurrency
  • Cybersecurity
  • Digital Health
  • EMR
  • Encryption
  • Fraud
  • Funding
  • Genomics
  • Hacked
  • Health Insurance
  • Healthcare Costs
  • Healthcare Innovation
  • Hospital News
  • Hospital Security
  • Identity Management
  • Investment Opportunity
  • news
  • Oncology
  • Patient Identity
  • Precision Medicine
  • Ransomware
  • Telehealth
  • Venture Capital

Nimbus-T Global inc

5570 Baldwin Way
Pleasanton, CA 94588

Copyright 2020

Translation


 Edit Translation

Blog Stats

  • 30,339 hits
Powered by Nimbus-T Global Inc. © 2020 All Rights Reserved
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok